Produk/indikasi berdaftar
Semaglutide
Metabolik & berat badan · Ozempic®, Wegovy®, Rybelsus®
AStatus rujukan
Kegunaan
→Type 2 diabetes, chronic weight management and product-specific approved indications.
Reseptor / sasaran
→GLP-1 receptor (GLP-1R) agonist.
Regulator
FDA-approved active ingredient in products including Ozempic, Rybelsus and Wegovy. Approval applies only to the registered product and formulation.
Cycle / tempoh
Long-term prescription treatment; injectable products are generally once weekly with label-directed titration.
Waktu
Use on the same day each week; label permits any time of day, with or without meals.